SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Menlo Park, CA.

Snowflake Inc

Snowflake shares rallied significantly following strong quarterly financial results that exceeded analyst expectations, bolstered by accelerated demand for the company's AI coding tools. While the community is divided between bullish sentiment regarding the company's AI-driven growth and skepticism over its high valuation and ongoing losses, intense trading volume has triggered a sharp upward move that has squeezed short positions.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom shares faced volatility following a fiscal fourth-quarter revenue outlook that fell slightly short of high-end estimates, despite the company reporting strong third-quarter results with massive growth in AI semiconductor revenue. Investors remain divided, with many bullish traders citing the company's long-term AI growth guidance—including targets for significant revenue expansion through 2028—as a signal to buy the dip, while others express caution regarding customer concentration and execution risks.

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

Credo Technology is experiencing significant downward pressure following its recent earnings report, despite beating estimates and raising guidance. Traders are debating whether the sell-off is an overreaction driven by concerns over margin compression, high customer concentration, and macro-economic factors, or if the stock is correcting from unsustainable valuation levels.

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc

Ultragenyx is trending following the failure of its late-stage clinical trial for the experimental Angelman syndrome drug apazunersen (GTX-102), which missed its primary and secondary endpoints. While some traders are expressing concern over the pipeline setback and potential for further downside, others are pointing to the company's established commercial portfolio and upcoming catalysts as reasons to remain long or accumulate shares.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is trending due to the expansion of its AI partnership with HPE to scale global data center infrastructure, sparking debate about the company's valuation and cloud growth potential ahead of its upcoming earnings report. While some investors remain cautious due to debt concerns and technical volatility, many point to its massive cloud backlog and AI infrastructure demand as catalysts for a potential rebound.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is experiencing significant buying pressure and volatility as investors look ahead to upcoming late-2026 clinical data readouts, specifically for its DM1 and FSHD programs. Traders are closely monitoring the company's recent leadership transition and the potential for a rebound in Elevidys revenue, while strong short interest continues to fuel speculation about a potential short squeeze or buyout.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is receiving attention as traders debate the project's long-term potential, focusing on its recent v5.0 mainnet upgrade, post-quantum cryptography features, and ongoing institutional adoption. While some participants are accumulating tokens in anticipation of a market-wide altcoin rally and the potential passage of the Clarity Act, others express significant skepticism, citing ongoing token dilution and poor historical price performance.

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell Technologies is trending following a "blockbuster" earnings report that featured record revenue and a significant upward revision to its annual outlook, fueled by surging demand for AI-optimized servers. While the market responded with a wave of analyst price target hikes, retail sentiment remains sharply divided between bulls expecting further gains toward the $600 level and traders cautioning against volatility and perceived algorithmic manipulation.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood shares are trending as investors respond to bullish price target hikes from major analysts, citing the company's growth in prediction markets and its expanded business lines. While many traders are optimistic about the stock's momentum and the growth of the Robinhood Chain, there is notable disagreement, with some users expressing frustration over perceived price suppression and manipulation, while others remain bearish on the platform's long-term outlook.

C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, predictive analytics, and Internet of Things applications in addition to a portfolio of turn-key AI applications. It operates through the following geographical segments: North America, Europe, The Middle East, and Africa, Asia Pacific, and Rest of World. The company was founded by Thomas M. Siebel, Patricia A. House and Stephen Maurice Ward, Jr. on January 8, 2009 and is headquartered in Redwood City, CA.

C3.ai Inc - Ordinary Shares - Class A

C3.ai Inc

C3.ai is trending following its fiscal fourth-quarter earnings report, which highlighted significant revenue declines and widened losses, leading to a polarized community reaction. While bears focus on the poor fundamentals and consistent cash burn, bulls are speculating on a potential short squeeze due to the stock's high short interest and confidence in the CEO's return and recent personal share purchase.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Bio-Techne Achieves Science Based Targets Validation and Reports Significant Progress Toward Climate Goals

Bio-Techne Achieves Science Based Targets Validation and Reports Significant Progress Toward Climate Goals Bio-Techne Achieves Science Based Targets Validation and Reports Significant Progress Toward Climate Goals PR Newswire MINNEAPOLIS, Sept. 1, 2026 Fiscal 2026 highlights:Science Based Targets...

TECH Stock Alert: Halper Sadeh LLC is Investigating Whether Bio-Techne Corporation is Obtaining a Fair Price for its Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Bio-Techne Corporation (NASDAQ: TECH) to Merck KGaA for $73.00 per share in cash. Halper Sadeh encourages Bio-Techne shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary...

Is Bio-Rad a Buy as Digital PCR Growth Meets a Premium Valuation?

BIO's digital PCR gains and recurring diagnostics base support growth, but a 40.2X forward P/E and muted 2026 outlook keep valuation risk in focus.

Are PAYO, TECH, CBAN Obtaining Fair Deals for their Shareholders?

Are PAYO, TECH, CBAN Obtaining Fair Deals for their Shareholders? Are PAYO, TECH, CBAN Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, Aug. 17, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may...

TECH Q4 Earnings Meet Estimates, Revenues Surpass, Stock Rises

Bio-Techne's Q4 revenues beat estimates as Diagnostics and Spatial Biology deliver strong organic growth, while its Merck deal remains in focus.

Bio-Techne Corrects Dividend Announcement

Bio-Techne Corrects Dividend Announcement Bio-Techne Corrects Dividend Announcement PR Newswire MINNEAPOLIS, Aug. 13, 2026 MINNEAPOLIS, Aug. 13, 2026 /PRNewswire/ -- Bio-TechneCorporation(NASDAQ: TECH) is issuing a correction to its dividend announcement released yesterday. The initial version...

Techne (TECH) Q4 Earnings Meet Estimates

Techne (TECH) delivered earnings and revenue surprises of 0.00% and +1.26%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Bio-Techne Posts Q4 Net Profit As Expenses Drop, Net Sales Improve

(RTTNews) - Bio-Techne Corporation (TECH), a provider of life science reagents, instruments, and services, on Wednesday reported net profit for the fourth quarter of fiscal 2026...

Bio-Techne Declares Dividend

Bio-Techne Declares Dividend Bio-Techne Declares Dividend PR Newswire MINNEAPOLIS, Aug. 12, 2026 MINNEAPOLIS, Aug. 12, 2026 /PRNewswire/ -- Bio-TechneCorporation(NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended June 30, 2026...

Bio-Techne Releases Fourth Quarter Fiscal 2026 Results

Bio-Techne Releases Fourth Quarter Fiscal 2026 Results Bio-Techne Releases Fourth Quarter Fiscal 2026 Results PR Newswire MINNEAPOLIS, Aug. 12, 2026 MINNEAPOLIS, Aug. 12, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ending...

Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for research and clinical diagnostic communities. The firm's products assist scientific investigations into biological processes and the nature and progress of specific diseases. It operates through the Protein Sciences and Diagnostics and Spatial Biology segments. The Protein Sciences segment develops and manufactures purified proteins, and reagent solutions. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products. The company was founded in 1976 and is headquartered in Minneapolis, MN.

Feed

News

Sentiment

Earnings

Fundamentals

Info

TECH Bio-Techne Corp

Fundamentals

Latest TECH News